Pfizer's strong pipeline of drugs and its fortress balance sheet make it an attractive investment at cheap valuation multiples. Click to read why PFE is a Buy.

Pfizer (NYSE: PFE) has a huge 7.1% dividend yield. That certainly compares favorably to the broader market's 1.2% yield and the average healthcare stock's yield of 1.7%. But Pfizer's lofty yield only ...

President Donald Trump and Pfizer's CEO today announced "TrumpRX" and lower drug prices. But what does Pfizer sell? Here's their popular drugs.

Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said ...

Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans unable to access the shots.

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this biotech stock.

The recommended schedule of standard childhood vaccines was recently reviewed and voted on by the CDC's revamped vaccine committee.

President Donald Trump and the CEO of Pfizer announce a new drug pricing deal to lower drug costs for Americans.

Pfizer Inc. Chief Executive Albert Bourla said the company secured a three-year grace period from President Trump’s promised tariffs on pharmaceuticals in a deal that would lower some of the company’s ...

President Trump on Tuesday announced that Pfizer had agreed to sell its products in the U.S. at “Most Favored Nation” pricing, one day after the administration required companies to ...

AZ's Board of Pharmacy said pharmacists can administer the new COVID-19 vaccine to anyone ages 6 years of age and older who want it.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for developing mRNA vaccines, but don’t be fooled into thinking these life-saving too ...